Skip to main content

We've saved some files called cookies on your device. These cookies are:

  • essential for the site to work
  • to help improve our website by collecting and reporting information on how you use it

We would also like to save some cookies to help tailor communications.

BETA
You're viewing an updated version of this service - your feedback will help us to improve it.

Contract Notice

Operational Excellence Programme

  • First published: 02 August 2022
  • Last modified: 02 August 2022
  • Version: N/A
  • This file may not be fully accessible.

  •  

Information icon

The buyer is not using this website to administer the notice.

To record your interest or obtain additional information or documents please find instructions within the Full Notice Text. (NOTE: Contract Award Notices and Prior Information Notices do not normally require a response)

Information icon
You are viewing an expired notice.

Contents

Summary

OCID:
ocds-h6vhtk-0357c5
Published by:
Cell and Gene Therapy Catapult
Authority ID:
AA79855
Publication date:
02 August 2022
Deadline date:
01 September 2022
Notice type:
Contract Notice
Has documents:
No
Has SPD:
No
Has Carbon Reduction Plan:
N/A

Abstract

We are looking to continue an Operational Excellence Programme on a wider scale, at different CGTC sites.

The Operational Excellence initiative is being established to ensure that the business can function in a high performing high-quality state across all main business streams: Stevenage Manufacturing and Innovation Centre, Braintree Manufacturing and Innovation Centre, London Research and Development (Technology, Process and Innovation), and Business Services.

The aim is to ensure advanced therapies are developed and delivered to patients rapidly and efficiently at a high standard of quality and with a sustainable business model.

Please access the procurement documents via the link below: https://catapultcgtc.wax-live.com/S2C/DisplayModules/TradeModules/Negotiations/Opportunities/ListEvents.aspx?ApplicationInstanceID=27adc89e-0cb2-4b51-9bc1-34061f10156f

Full notice text

Contract notice

Section I: Contracting authority

I.1) Name and addresses

CELL AND GENE THERAPY CATAPULT

07964711

12TH FLOOR TOWER WING,GUY'S HOSPITAL, GREAT MAZE POND

LONDON

SE19RT

UK

E-mail: procurement@ct.catapult.org.uk

NUTS: UKI44

Internet address(es)

Main address: https://ct.catapult.org.uk/

I.3) Communication

The procurement documents are available for unrestricted and full direct access, free of charge at:

https://catapultcgtc.wax-live.com/S2C/DisplayModules/TradeModules/Negotiations/Opportunities/ListEvents.aspx?ApplicationInstanceID=27adc89e-0cb2-4b51-9bc1-34061f10156f


Additional information can be obtained from the abovementioned address


Tenders or requests to participate must be sent electronically to:

https://catapultcgtc.wax-live.com/S2C/DisplayModules/TradeModules/Negotiations/Opportunities/ListEvents.aspx?ApplicationInstanceID=27adc89e-0cb2-4b51-9bc1-34061f10156f


I.4) Type of the contracting authority

Body governed by public law

I.5) Main activity

Health

Section II: Object

II.1) Scope of the procurement

II.1.1) Title

Operational Excellence Programme

II.1.2) Main CPV code

80521000

 

II.1.3) Type of contract

Services

II.1.4) Short description

We are looking to continue an Operational Excellence Programme on a wider scale, at different CGTC sites.

The Operational Excellence initiative is being established to ensure that the business can function in a high performing high-quality state across all main business streams: Stevenage Manufacturing and Innovation Centre, Braintree Manufacturing and Innovation Centre, London Research and Development (Technology, Process and Innovation), and Business Services.

The aim is to ensure advanced therapies are developed and delivered to patients rapidly and efficiently at a high standard of quality and with a sustainable business model.

If you are interested, please use the following link to access the procurement documents: https://catapultcgtc.wax-live.com/S2C/DisplayModules/TradeModules/Negotiations/Opportunities/ListEvents.aspx?ApplicationInstanceID=27adc89e-0cb2-4b51-9bc1-34061f10156f

II.1.5) Estimated total value

Value excluding VAT: 500 000.00  GBP

II.1.6) Information about lots

This contract is divided into lots: No

II.2) Description

II.2.2) Additional CPV code(s)

71621000

II.2.3) Place of performance

NUTS code:

UKJ

II.2.4) Description of the procurement

We are looking to continue an Operational Excellence Programme on a wider scale, at different CGTC sites.

The Operational Excellence initiative is being established to ensure that the business can function in a high performing high-quality state across all main business streams: Stevenage Manufacturing and Innovation Centre, Braintree Manufacturing and Innovation Centre, London Research and Development (Technology, Process and Innovation), and Business Services.

The aim is to ensure advanced therapies are developed and delivered to patients rapidly and efficiently at a high standard of quality and with a sustainable business model.

Please access the procurement documents via the link below: https://catapultcgtc.wax-live.com/S2C/DisplayModules/TradeModules/Negotiations/Opportunities/ListEvents.aspx?ApplicationInstanceID=27adc89e-0cb2-4b51-9bc1-34061f10156f

II.2.5) Award criteria

Price is not the only award criterion and all criteria are stated only in the procurement documents

II.2.7) Duration of the contract, framework agreement or dynamic purchasing system

Start: 09/01/2023

End: 08/01/2028

This contract is subject to renewal: Yes

Description of renewals:

2 years +1 +1 +1 years

II.2.9) Information about the limits on the number of candidates to be invited

II.2.10) Information about variants

Variants will be accepted: No

II.2.11) Information about options

Options: No

II.2.13) Information about European Union funds

The procurement is related to a project and/or programme financed by European Union funds: No

Section IV: Procedure

IV.1) Description

IV.1.1) Type of procedure

Restricted procedure

IV.1.8) Information about Government Procurement Agreement (GPA)

The procurement is covered by the Government Procurement Agreement: Yes

IV.2) Administrative information

IV.2.2) Time limit for receipt of tenders or requests to participate

Date: 01/09/2022

Local time: 12:00

IV.2.4) Languages in which tenders or requests to participate may be submitted

EN

Section VI: Complementary information

VI.1) Information about recurrence

This is a recurrent procurement: No

VI.4) Procedures for review

VI.4.1) Review body

Catapult Cell and Gene Therapy

London

UK

VI.5) Date of dispatch of this notice

01/08/2022

Coding

Commodity categories

ID Title Parent category
71621000 Technical analysis or consultancy services Analysis services
80521000 Training programme services Training facilities

Delivery locations

ID Description
100 UK - All

Alert region restrictions

The buyer has restricted the alert for this notice to suppliers based in the following regions.

ID Description
There are no alert restrictions for this notice.

About the buyer

Main contact:
procurement@ct.catapult.org.uk
Admin contact:
N/a
Technical contact:
N/a
Other contact:
N/a

Further information

Date Details
No further information has been uploaded.

0800 222 9004

Lines are open 8:30am to 5pm Monday to Friday.

Rydym yn croesawu galwadau'n Gymraeg.

We welcome calls in Welsh.